Related references
Note: Only part of the references are listed.Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney Transplantation
Aurora Paez-Vega et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells
Philippe Gatault et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D plus /R plus Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy
Marta Jarque et al.
TRANSPLANTATION (2018)
Interventions for Treating 3-or 4-part proximal humeral fractures in elderly patient: A network meta-analysis of randomized controlled trials
Shaolong Du et al.
INTERNATIONAL JOURNAL OF SURGERY (2017)
T cell responses to cytomegalovirus
Paul Klenerman et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
Oriol Manuel et al.
CLINICAL INFECTIOUS DISEASES (2013)
Efficacy of allergen-specific immunotherapy for atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials
Jung Min Bae et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Comparison of Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV Quantiferon Gamma Interferon-Releasing Assays in Assessing Risk of CMV Infection in Kidney Transplant Recipients
Davide Abate et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Influence of Cytomegalovirus Disease in Outcome of Solid Organ Transplant Patients
L. Linares et al.
TRANSPLANTATION PROCEEDINGS (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients
A. Asberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Checking consistency in mixed treatment comparison meta-analysis
S. Dias et al.
STATISTICS IN MEDICINE (2010)
2009 Updated Method Guidelines for Systematic Reviews in the Cochrane Back Review Group
Andrea D. Furlan et al.
SPINE (2009)
Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil
S. Brurn et al.
TRANSPLANTATION PROCEEDINGS (2008)
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
C Paya et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
S Sagedal et al.
KIDNEY INTERNATIONAL (2004)
Combination of direct and indirect evidence in mixed treatment comparisons
G Lu et al.
STATISTICS IN MEDICINE (2004)
A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.
DF Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation
IG Sia et al.
JOURNAL OF INFECTIOUS DISEASES (2000)